- Home
- FOSL vs THTX Comparison
FOSL vs THTX Comparison
Compare FOSL & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- THTX
- Stock Information
- Founded
- FOSL 1984
- THTX 1993
- Country
- FOSL United States
- THTX Canada
- Employees
- FOSL N/A
- THTX N/A
- Industry
- FOSL Consumer Specialties
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- THTX Health Care
- Exchange
- FOSL Nasdaq
- THTX Nasdaq
- Market Cap
- FOSL 100.0M
- THTX 93.3M
- IPO Year
- FOSL 1993
- THTX N/A
- Fundamental
- Price
- FOSL $1.76
- THTX $1.77
- Analyst Decision
- FOSL
- THTX Hold
- Analyst Count
- FOSL 0
- THTX 1
- Target Price
- FOSL N/A
- THTX N/A
- AVG Volume (30 Days)
- FOSL 522.1K
- THTX 161.1K
- Earning Date
- FOSL 03-12-2025
- THTX 02-19-2025
- Dividend Yield
- FOSL N/A
- THTX N/A
- EPS Growth
- FOSL N/A
- THTX N/A
- EPS
- FOSL N/A
- THTX N/A
- Revenue
- FOSL $1,223,954,000.00
- THTX $84,316,000.00
- Revenue This Year
- FOSL N/A
- THTX $5.78
- Revenue Next Year
- FOSL N/A
- THTX $2.47
- P/E Ratio
- FOSL N/A
- THTX N/A
- Revenue Growth
- FOSL N/A
- THTX 5.75
- 52 Week Low
- FOSL $0.75
- THTX $1.08
- 52 Week High
- FOSL $2.61
- THTX $2.18
- Technical
- Relative Strength Index (RSI)
- FOSL 49.72
- THTX 52.97
- Support Level
- FOSL $1.61
- THTX $1.67
- Resistance Level
- FOSL $1.97
- THTX $1.83
- Average True Range (ATR)
- FOSL 0.16
- THTX 0.13
- MACD
- FOSL -0.02
- THTX -0.04
- Stochastic Oscillator
- FOSL 35.71
- THTX 28.07
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.